Short-term, low concentration of Temozolomide modulates proteins associated with glucose and amino acid metabolism and antigen processing and presentation in LN18 and A172 glioblastoma cell lines

Glioblastoma is the most aggressive and invasive form of brain tumour. More than half of the patients with glioblastoma develop resistance to chemotherapy. This study discovers indicators that can predict how and when resistance to chemotherapy occurs.